lomefloxacin has been researched along with Pulmonary Disease, Chronic Obstructive in 2 studies
lomefloxacin: structure given in first source
lomefloxacin : A fluoroquinolone antibiotic, used (generally as the hydrochloride salt) to treat bacterial infections including bronchitis and urinary tract infections. It is also used to prevent urinary tract infections prior to surgery.
Pulmonary Disease, Chronic Obstructive: A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.
Excerpt | Relevance | Reference |
---|---|---|
"Lomefloxacin is a difluorinated quinolone with excellent activity against a wide range of pathogens including those responsible for acute exacerbations of chronic bronchitis (AECB)." | 7.71 | Safety and effectiveness of lomefloxacin in patients with acute exacerbation of chronic bronchitis (AECB) chronically treated with oral theophyllines. ( Cantoni, V; Melani, AS; Pirrelli, M; Sarlo, F, 2001) |
"Lomefloxacin is a difluorinated quinolone with excellent activity against a wide range of pathogens including those responsible for acute exacerbations of chronic bronchitis (AECB)." | 3.71 | Safety and effectiveness of lomefloxacin in patients with acute exacerbation of chronic bronchitis (AECB) chronically treated with oral theophyllines. ( Cantoni, V; Melani, AS; Pirrelli, M; Sarlo, F, 2001) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cazzola, M | 1 |
Matera, MG | 1 |
Tufano, MA | 1 |
Catalanotti, P | 1 |
Polverino, M | 1 |
Cantoni, V | 2 |
Fici, F | 1 |
Sarlo, F | 2 |
Rossi, F | 1 |
Melani, AS | 1 |
Pirrelli, M | 1 |
2 other studies available for lomefloxacin and Pulmonary Disease, Chronic Obstructive
Article | Year |
---|---|
Pulmonary disposition of lomefloxacin in patients with acute exacerbation of chronic obstructive pulmonary disease. A multiple-dose study.
Topics: Administration, Oral; Anti-Infective Agents; Antitubercular Agents; Bronchi; Bronchoalveolar Lavage | 2001 |
Safety and effectiveness of lomefloxacin in patients with acute exacerbation of chronic bronchitis (AECB) chronically treated with oral theophyllines.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Anti-Infective Agents; Bronchitis; Cross-Sectional | 2001 |